BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$151M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$126M |
| 3 |
Alibaba
BABA
|
+$92.6M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$71M |
| 5 |
Lam Research
LRCX
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.15B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Apple
AAPL
|
+$837M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$723M |
| 5 |
Microsoft
MSFT
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7% |
| 2 | Financials | 5.86% |
| 3 | Healthcare | 5.05% |
| 4 | Consumer Discretionary | 4.98% |
| 5 | Industrials | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| $135M | 0.32% |
3,449,864
-95,241
| -3% | -$3.82M |
|
52
PUT
Netflix
NFLX
$318B
| $133M | 0.31% |
49,800
+8,700
| +21% | +$260K |
|
53
PUT
Johnson & Johnson
JNJ
$631B
| $132M | 0.31% |
10,266
+707
| +7% | +$98.6K |
|
54
iShares MSCI Japan ETF
EWJ
$22.6B
| $132M | 0.31% |
2,602,134
+703,251
| +37% | +$38.6M |
|
55
CALL
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.4B
| $132M | 0.31% |
5,650
+370
| +7% | +$92.3K |
|
56
Intel
INTC
$492B
| $128M | 0.3% |
2,732,817
-2,362,126
| -46% | -$111M |
|
|
57
CALL
iShares Russell 2000 ETF
IWM
$81.5B
| $127M | 0.3% |
9,500
+5,634
| +146% | +$841K |
|
58
PUT
Chevron
CVX
$382B
| $126M | 0.3% |
11,609
+2,337
| +25% | +$271K |
|
|
59
PUT
VanEck Gold Miners ETF
GDX
$27.6B
| $126M | 0.3% |
59,728
+13,665
| +30% | +$268K |
|
60
PUT
Visa
V
$675B
| $125M | 0.3% |
9,509
+2,649
| +39% | +$366K |
|
61
Merck
MRK
$323B
| $124M | 0.29% |
1,700,886
-1,907,461
| -53% | -$135M |
|
62
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $123M | 0.29% |
4,065
| – | – |
|
63
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $123M | 0.29% |
15,128
+8,500
| +128% | +$712K |
|
|
64
CALL
VanEck Gold Miners ETF
GDX
$27.6B
| $122M | 0.29% |
57,625
-28,243
| -33% | -$554K |
|
65
Gilead Sciences
GILD
$165B
| $120M | 0.28% |
1,913,676
-1,360,163
| -42% | -$95.1M |
|
66
Baidu
BIDU
$37.1B
| $117M | 0.28% |
736,250
-5,875
| -0.8% | -$1.1M |
|
67
CALL
iShares MSCI EAFE ETF
EFA
$79.8B
| $116M | 0.27% |
19,661
+19,000
| +2,874% | +$1.19M |
|
|
68
Alphabet (Google) Class C
GOOG
$4.35T
| $115M | 0.27% |
2,213,820
-21,539,960
| -91% | -$1.15B |
|
69
Ambev
ABEV
$45.4B
| $114M | 0.27% |
29,040,702
+1,660,110
| +6% | +$7.09M |
|
|
70
Johnson & Johnson
JNJ
$631B
| $114M | 0.27% |
880,488
-860,292
| -49% | -$120M |
|
71
PUT
Regeneron Pharmaceuticals
REGN
$83.2B
| $113M | 0.27% |
3,016
-206
| -6% | -$75.4K |
|
72
Goldman Sachs
GS
$301B
| $111M | 0.26% |
666,221
-267,098
| -29% | -$53.9M |
|
73
PUT
Walt Disney
DIS
$178B
| $110M | 0.26% |
10,006
-1,799
| -15% | -$205K |
|
|
74
CALL
Microsoft
MSFT
$3.76T
| $110M | 0.26% |
10,784
-363
| -3% | -$38.9K |
|
75
CALL
Pfizer
PFE
$154B
| $108M | 0.26% |
26,115
+3,924
| +18% | +$163K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2018 Portfolio in Review
As of Q4 2018, BNP Paribas Financial Markets held 4,572 positions worth $42.3B, down 38% from $67.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets withdrew a net $18.9B in Q4 2018, closing 248 positions and reducing 2,296 holdings. Its most notable exit was Aetna Inc, an estimated $141M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 9.5% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in HUTCHMED worth $8.84M.
- BNP Paribas Financial Markets's largest Q4 2018 buy was HUTCHMED: 382,749 shares worth $8.84M.
- BNP Paribas Financial Markets added most to Celgene Corp in Q4 2018, an estimated $151M increase.
- BNP Paribas Financial Markets's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.15B.
- BNP Paribas Financial Markets fully exited Aetna Inc in Q4 2018, selling an estimated $141M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $42.3B portfolio in Q4 2018.
- BNP Paribas Financial Markets opened 126 new positions and closed 248 in Q4 2018.
- BNP Paribas Financial Markets's portfolio value fell 38% quarter-over-quarter to $42.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2018, filed 12 Feb 2019.